Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

US Patent 10322107 · Granted Jun 18, 2019

Estimated economic value: $71,028,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adenosine 2 receptor antagonists2025
Adenosine 2 receptor antagonists2025
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeu2025
Immunotherapeutic tumor treatment method2024
Immunotherapeutic tumor treatment method2024
Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeu2023
Multi-arm polymeric alkanoate conjugates2023
MEK inhibitors and methods of their use2023
Oligomer-corticosteroid conjugates2022
Process for making compounds for use in the treatment of cancer2022
N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives2022
N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives2022